GlassScriptPhysician profile
Stephanie S Wellborn
NPI 1063828408
$4,878.37
in general payments reported to CMS, 2019-2025
43 companies · $1,015 in 2025
The $1,015 reported for 2025 was more than what 81% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $677 · 2022: $683 · 2023: $1,369 · 2024: $1,134 · 2025: $1,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,423 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,422.86 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $679.83 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $616.67 | 2021-2025 | |
| Lilly USA, LLC | $425.53 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $362.83 | 2021-2025 | Spravato |
| Astellas Pharma US INC | $299.51 | 2021-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $226.11 | 2021-2023 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $211.73 | 2021-2024 | |
| Sanofi-Aventis U.S. LLC | $181.20 | 2024-2025 | |
| Exact Sciences Corporation | $161.61 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.30 | 2023-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $146.66 | 2021-2025 | Farxiga, Fasenra, Airsupra |
| Pfizer INC. | $144.44 | 2023-2025 | |
| Amgen INC. | $139.20 | 2023-2025 | Prolia, Evenity, Otezla |
| Dexcom, INC. | $91.45 | 2023 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $90.79 | 2023-2025 | Rexulti |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Wellborn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.